Breaking Sitting with High-intensity Interval Training for Brain Health
University of Illinois at Urbana-Champaign · with Northeastern University, National Institute on Aging (NIA) · NCT06243016
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 54
- US sites recruiting
- 1
- Study start
- May 7, 2024
- Record last updated
- February 7, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min high intensity interval training (HIIT) breaks compared to light intensity interval training (LIIT) will improve brain health in cognitively normal older adults. This trial will test the feasibility of HIIT breaks to sitting. It will also address several important but unanswered questions: (1) Does interrupting sitting with short HIIT breaks improve frontoparietal function? (2) Can interrupting sitting with HIIT breaks improve cognitive functions?
Being studied: High-Intensity Interval Training (HIIT) Breaks to Sitting; Light-Intensity Interval Training (LIIT) Breaks to Sitting
Conditions: Aging
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 40-75 years
- BMI \<40 kg/m2
- Sedentary (≥ 6 h/day sitting by a survey question)
- Physically inactive adults based on the CSEP-PATH: Physical Activity and Sedentayr Behaviour Questionnaire (PASB-Q) Adult (low or medium physical activity range equivalent to less than 300 min of moderate intensity physical activity per week)
- Capable of exercising vigorously based on the Physical Activity Readiness Questionnaire (PARQ+)
- Has a medical clearance for maximal exercise and HIIT from a physician
- Normotensive or participant's blood pressure is controlled
- Intelligence quotient (IQ) ≥85
- Fasting plasma glucose \<126 mg/dL
- Good or corrected vision and hearing
- Right-handed
- No significant abnormalities on the ECG during the maximal exercise test
- No signs and symptoms that suggest an underlying cardiovascular disease as recorded during the maximal exercise test by a study physician.
- No indications to prematurely stop the maximal exercise test as outlined by the ACSM's Guidelines for Exercise Testing and Prescription
- Concussion if more than 12 months before the study screening.
- History of cancer but in full remission for at least 12 months and no history of chemotherapy, signed off by the physician or an oncologist
Exclusion Criteria
- Physical disability or musculoskeletal disease prohibitive to vigorous exercise
- Learning disabilities
- Cognitive impairment (MoCA \<26)
- Type 1 or 2 diabetes
- Neurological condition (e.g., Multiple Sclerosis, Parkinson, Dementia, Mild Cognitive Impairment)
- Color blindness
- Brain injury (e.g., traumatic brain injury, stroke, concussion)
- Migraine headaches
- Presence of other health conditions that may be exacerbated by exercise
- History of heart disease
- High cholesterol not controlled by medication
- Signs and symptoms indicative of underlying cardiovascular disease
- A chronic pulmonary disease
- Emphysema
- Pulmonary embolus
- Asthma
- History of renal disease
- History of seizures
- A neuropsychiatric disorder
- Osteoporosis if it interferes with an individual's ability to exercise
- Severe back problems
- Severe arthritis if it interferes with an individual's ability to exercise
- Thyroid disorder not controlled by medication
- Polyneuropathy
- Sleep disorders
- Acquired immunodeficiency syndrome (AIDS)
- Hepatitis C
- History of long Coronavirus Disease 2019 (COVID-19)
- History of cancer if not in full remission for at least 12 months and if a participant had the history of chemotherapy
- Current or past smoking \<12 months
- Corticosteroid intake \< 31 days before screening
- Opioids taken \< 6 months from screening
- Anabolic androgens taken \< 31 days before screening
- A serious illness or hospitalization in the last six months
- Currently taking medications that can affect the central nervous system (except for anxiolytics)
- Current participation in an ongoing trial likely to influence exercise ability or cognitive function
Recruiting US locations
University of Illinois at Urbana-Champaign
Urbana, IL 61801
Site contact: Dominika M Pindus, PhD · 2173007317 · pindus@illinois.edu
Study contacts (from the official record)
- Dominika M Pindus, Ph.D. · 217-300-7317 · pindus@illinois.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65